ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
5,970.84
-1.11%
US Tech 100
20,897.20
-1.35%
다우존스 지수
42,992.21
-0.77%
Bitcoin
94,223.98
0.07%
Registration Strip Icon for alerts 실시간 알림, 사용자 정의 포트폴리오 및 시장 동향을 받으려면 등록하세요.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 미국
  5. NASDAQ
  6. C4 Therapeutics Inc (CCCC)

  7. C4 Therapeutics Inc (CCCC) 뉴스

CCCC

C4 Therapeutics (CCCC)

C4 Therapeutics Inc
일자:
정렬 기준:
 검색 관련기사 보기:NASDAQ:CCCC
일자시간출처헤드라인심볼기업
2024/12/0923:49Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CCCCC4 Therapeutics Inc
2024/12/0902:30GlobeNewswire Inc.C4 Therapeutics Presents Cemsidomide Phase 1 Data at the American Society for Hematology (ASH) Annual Meeting that Demonstrated Potential to Become Best-in-Class IKZF1/3 DegraderNASDAQ:CCCCC4 Therapeutics Inc
2024/11/2021:11Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CCCCC4 Therapeutics Inc
2024/11/2021:00GlobeNewswire Inc.C4 Therapeutics Appoints Accomplished Oncology Executive Steve Hoerter to Board of DirectorsNASDAQ:CCCCC4 Therapeutics Inc
2024/11/1906:43Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:CCCCC4 Therapeutics Inc
2024/11/1606:06Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:CCCCC4 Therapeutics Inc
2024/11/1606:05Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:CCCCC4 Therapeutics Inc
2024/11/1506:05Edgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:CCCCC4 Therapeutics Inc
2024/11/1505:30Edgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:CCCCC4 Therapeutics Inc
2024/11/1505:30Edgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:CCCCC4 Therapeutics Inc
2024/11/1423:01Edgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:CCCCC4 Therapeutics Inc
2024/11/1414:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:CCCCC4 Therapeutics Inc
2024/11/1414:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:CCCCC4 Therapeutics Inc
2024/11/1406:58Edgar (US Regulatory)Form SUPPL - Voluntary Supplemental Material by Foreign Issuers [Section 11(a)]NASDAQ:CCCCC4 Therapeutics Inc
2024/11/1406:57Edgar (US Regulatory)Form SUPPL - Voluntary Supplemental Material by Foreign Issuers [Section 11(a)]NASDAQ:CCCCC4 Therapeutics Inc
2024/11/1306:17Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CCCCC4 Therapeutics Inc
2024/11/1306:17Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CCCCC4 Therapeutics Inc
2024/11/1306:17Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CCCCC4 Therapeutics Inc
2024/11/1306:17Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CCCCC4 Therapeutics Inc
2024/11/0621:00GlobeNewswire Inc.C4 Therapeutics Announces First Patient Dosed in CFT8919 Clinical TrialNASDAQ:CCCCC4 Therapeutics Inc
2024/11/0523:00GlobeNewswire Inc.C4 Therapeutics to Present Data from the Ongoing Phase 1/2 Trial of Cemsidomide in Multiple Myeloma and Non-Hodgkin’s Lymphoma at the American Society of Hematology (ASH) Annual MeetingNASDAQ:CCCCC4 Therapeutics Inc
2024/11/0106:27Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:CCCCC4 Therapeutics Inc
2024/11/0106:26Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:CCCCC4 Therapeutics Inc
2024/10/3120:12Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:CCCCC4 Therapeutics Inc
2024/10/3120:07Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CCCCC4 Therapeutics Inc
2024/10/3120:00GlobeNewswire Inc.C4 Therapeutics Reports Third Quarter 2024 Financial Results and Recent Business HighlightsNASDAQ:CCCCC4 Therapeutics Inc
2024/10/3005:31Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CCCCC4 Therapeutics Inc
2024/10/3005:30Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:CCCCC4 Therapeutics Inc
2024/10/2905:01GlobeNewswire Inc.C4 Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:CCCCC4 Therapeutics Inc
2024/10/2307:06Edgar (US Regulatory)Form SC 13G - Statement of Beneficial Ownership by Certain InvestorsNASDAQ:CCCCC4 Therapeutics Inc
 검색 관련기사 보기:NASDAQ:CCCC

최근 히스토리

USOTC
ADDYY
Adidas (QX)
NASDAQ
QQQ
Invesco QQQ Trust Series 1
COIN
BTCUSD
Bitcoin
COIN
AVAXUSD
Avalanche
AMEX
XLE
Energy Select Sector SPDR
COIN
SOLUSD
Solana
FX
USDEUR
US Dollar vs Euro
USOTC
RHHBY
Roche (QX)
USOTC
BASFY
BASF (QX)
USOTC
DTEGY
Deutsche Telekom (QX)
NYSE
MRK
Merck
NYSE
CVX
Chevron
COIN
DOGEUSD
Dogecoin
NASDAQ
MSFT
Microsoft
CCOM
SILVER
SILVER
NASDAQ
GOOGL
Alphabet
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

대한민국
회사 소개
사업
Popular
앱 받기
App Store
Google Play

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2024 ADVFN PLC - 모든 권리 보유